Leases

9 Months Ended

Mar. 29, 2025

Our leases primarily include our worldwide office and research and development facilities which are all classified as operating leases. Certain leases include renewal options at our discretion. The leases expire at various dates through fiscal 2034, some of which include options to extend the lease for up to seven years. For the three months ended March 2025 and March 2024, we recorded operating lease expense of approximately $3.1 million and $3.0 million, respectively. For the nine months ended March 2025 and March 2024, we recorded operating lease expense of approximately $9.6 million and $8.8 million, respectively. Our short-term leases are immaterial and we do not have finance leases.

As of March 2025 and June 2024, the components of leases are as follows (in millions):


	March		June
	2025		2024
Operating lease right-of-use assets	$	44.4	$	46.8
Operating lease liabilities	$	11.6	$	11.5
Operating lease liabilities, long-term	35.6		37.9
Total operating lease liabilities	$	47.2	$	49.4

Supplemental cash flow information related to leases, including from acquisitions, is as follows (in millions):


	Nine Months Ended
	March
	2025		2024
Cash paid for operating leases included in operating cash flows	$	10.2	$	8.2
Supplemental non-cash information related to lease liabilities arising from obtaining right-of-use assets	$	6.2	$	4.1

As of March 2025, the weighted average remaining lease term is 5.90 years, and the weighted average discount rate is 5.17%.

Future minimum lease payments for the operating lease liabilities are as follows (in millions):


Fiscal Year	Operating Lease Payments
Remainder of 2025	$	4.2
2026	12.8
2027	9.0
2028	7.2
2029	6.3
Thereafter	15.2
Total future minimum operating lease payments	54.7
Less: interest	(7.5)
Total lease liabilities	$	47.2